Episode Description
In about five weeks, adland will take over a small resort city in the south of France for a weeklong industry bonanza.
The 2026 Cannes Lions International Festival of Creativity is on the horizon, slated for the last full week of June and rest assured, the medical marketing community will be there in force.
Nearly one month ago, the juries for Health & Wellness Lions and the Pharma Lions were announced, featuring a few North American-based creatives, including Chris Charles, executive creative director of Real Chemistry subsidiary 21Grams.
You might remember Chris and his team for their Gold Pharma Lions-winning work on behalf of Biogen for Friedreich’s Back, a darkly humorous campaign focused on the often terminal, rare condition Friedreich’s ataxia.
For this week’s episode, Chris joins executive editor Jack O'Brien for a conversation about the early stages of the sizable task undertaken by the Cannes pharma jury and what trends he’s keeping an eye on as they analyze the nominated work.
He also reflects on the success of Frederich’s Back and why Cannes is important to pharma marketers.
For our Trends segment, we’re talking about the frustrating, mixed public health messaging surrounding the hantavirus cruise ship outbreak.
Check us out at: mmm-online.com
Follow us:
YouTube: @MMM-online
TikTok: @MMMnews
Instagram: @MMMnewsonline
Twitter/X: @MMMnews
LinkedIn: MM+M
To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.
Music: “Deep Reflection” by DP and Triple Scoop Music.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Listen On
